Submitted by admin on

Genoox, an AI-driven genomic data interpretation software firm, was acquired for $70M by preclinical-stage biotechnology company QIAGEN to add next-generation sequencing (NGS) data analysis capabilities to support clinical decision-making. 

Seller Name
Genoox
Buyer Name
Qiagen
Deal Value
$70M
Value Type